| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.43 | 0.007 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.38 | 0.01 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |